ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 728979 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 728979; 2) Community: the network communities that were significantly associated with the response to NSC 728979; 3) Molecule: the relationships between components within communities and NSC 728979; 4) MDR: the compounds that were significantly associated with the NSC 728979.

NSC Compound Enrichment Correlation
NSC 63839 Triacryloylhexahydro-s-triazine 0.00170676579199123 -0.036177361
NSC 726770 Cis-6-(2-dimethylamino-1-ethyl)-5,6,12,13-tetrahydro-2,3-dim ethoxy-8,9-(methylenedioxy)-5,11-dioxo-11H-indeno-[1,2-c]iso quinoline 0.00170676579199123 0.60144101
NSC 726971 6-[3-(1,1'-Dimethyl-2-hydroxyethyl)amino-1-propyl]-5,6-dihyd ro-2,3-dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1, 2-c]isoquinoline Hydrochloride 0.00170676579199123 0.58802309
NSC 107660 Actinomycin Pip T.beta. 0.00248478006478608 0.23262181
NSC 132483 Aminopterin Derivative 0.00248478006478608 0.57259384
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.00248478006478608 0.49058984
NSC 49689 Null 0.00248478006478608 0.11162448
NSC 606985 Camptothecin Derivative 0.00248478006478608 0.61751688
NSC 613327 Gemcitabine Y 0.00248478006478608 0.67414438
NSC 616348 Irinotecan hydrochloride 0.00248478006478608 0.67882749
Total:100  Current:6    [First] [Prev] [Next] [Last]